Bayer Aktiengesellschaft (BAYZF) CEO Werner Baumann on Q3 2019 Results - Earnings Call Transcript [Seeking Alpha]
BAYER AG S/ADR (BAYRY)
NASDAQ:AMEX Investor Relations:
investor.bayer.com
Company Research
Source: Seeking Alpha
Bayer Aktiengesellschaft (BAYZF) CEO Werner Baumann on Q3 2019 Results - Earnings Call Transcript Bayer Aktiengesellschaft ( OTCPK:BAYZF Company Participants Oliver Maier - Head of IR Werner Baumann - CEO Wolfgang Nickl - CFO Stefan Oelrich - Head of Pharmaceuticals Division Heiko Schipper - Head of Consumer Health Division Liam Condon - President of Bayer Crop Science Division Conference Call Participants Vincent Andrews - Morgan Stanley Wimal Kapadia - Bernstein Jeff Zekauskas - JPMorgan Sachin Jain - Bank of America Emmanuel Papadakis - Barclays Richard Vosser - JP Morgan Joe Lockey - Morgan Stanley Keyur Parekh - man Sachs Michael Leuchten - UBS Operator Ladies and gentlemen, thank you for standing by. Welcome to Bayer's Investor and Analyst Conference Call on the Third Quarter 2019 Results. Throughout today’s recorded presentation, all participants will be in listen-only mode. The presentation will be followed by question-and-answer session. [Operator Instructions] And I would no
Show less
Read more
Impact Snapshot
Event Time:
BAYRY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BAYRY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BAYRY alerts
High impacting BAYER AG S/ADR news events
Weekly update
A roundup of the hottest topics
BAYRY
News
- Study that said glyphosate herbicide is safe retracted 25 years after publication [Yahoo! Finance Canada]Yahoo! Finance Canada
- Bayer Starts Phase IIa Study for Treatment of Patients With Alport SyndromeBusiness Wire
- Taboo no more: Leaders gather to discuss women's health [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- Trump administration backs Bayer as Roundup fight moves toward Supreme Court [FOX Business Network]FOX Business Network
- RSNA25: Pediatric Study for Bayer's Investigational MRI Contrast Agent Gadoquatrane Meets Primary and Secondary EndpointsBusiness Wire